About Hospira News & Media Investor RelationsIn the Community
Annual Reports/
Proxies
Quarterly Reports/
Supplemental Tables
SEC Filings
Insider Transactions
Tax Information for Shareholders
Stock Quote
Stock Chart
Shareholder FAQ
Analyst Coverage
Financial Press
Releases
Presentations
IR Calendar
Email Alerts  
Hospira Leadership
Board of Directors
Board Committees
and Charters
Corporate Governance
Guidelines
Share Ownership Guidelines
Long Term
Incentives Policy
Hospira Code of Business Conduct

Webcast ImageWebcast
Q2 2008 Hospira Earnings Conference Call (Replay)
08/06/08 at 8:00 a.m. CT

Segment / Product Line Reporting Changes - New!

To better reflect how Hospira currently manages its business, as well as its strategic focus on certain product lines, beginning in the first quarter of 2008 we are re-aligning our segment and product line reporting presentation. Click here to view the historical quarterly net sales for 2007 and 2006 re-cast under these new categories. Please note that 2007’s net sales include 11 months of Mayne Pharma Limited’s net sales classified in the appropriate product line; Mayne is not broken out separately. The net sales for 2006 do not include Mayne’s sales.


Corporate Profile

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest offerings of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Headquartered north of Chicago in Lake Forest, Ill., Hospira has more than 14,000 employees worldwide.
Want to know more? Click here for Hospira’s investor presentation.


Shareholder Information

Exchange
The common stock is listed on the New York Stock Exchange under the symbol "HSP."

Transfer Agent
Computershare Investor Services
P.O. Box 43078
Providence, RI 02940-3078
800-821-1238
www.computershare.com
shareholder@computershare.com

For shareholders of Mayne Pharma stock – click here for information regarding Mayne Pharma shares.

Hospira Investor Relations Contact Information

For questions regarding Investor Relations, please contact Hospira through our online investor information e-mail.

Hospira Mailing Address:
Hospira, Inc.
275 North Field Drive
Dept. 051M, Bldg. H1-2S
Lake Forest, IL 60045

Shareholder E-Delivery

Are you a Hospira shareholder? If so, you can elect to receive your annual report, proxy statement and other investor-related materials online, reducing the amount of mailings you receive from us. Using Shareholder E-Delivery also promotes less paper usage, a more environmentally friendly practice, and helps reduce company costs. If this is an option that interests you, sign up today!


2007 Annual Report
Hospira, Inc.
NYSE: HSP

Current Price:$38.89
Change (%): - 0.32 (0.82%)
High:$39.36
Low:$38.74
Volume:666,458
08/19/08 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Tax Information for Shareholders
Download Documentation Tax/Cost Basis Information
Download Documentation U.S. Tax Reporting Statement
Download Documentation Canadian Tax Reporting Statement
Get help downloading or viewing the above file types
Receive E-mail AlertsE-mail Alert Icon
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!